Astellas Pharma joined PPMD for a webinar on May 19, 2021 to provide an update on the company’s ASP0367 development program. Research & Clinical Trial Webinars,Webinars 3 years ago You may also like 1:01:12 Engaging Families in Care Guideline Development (November 2018) 6 years ago Care Webinars,Research & Clinical Trial Webinars,Webinars 47:47 PolarisDMD: Phase 3 Clinical Trial of Edasalonexent, a Novel NF-kB Inhibitor (November 2018) 6 years ago Research & Clinical Trial Webinars,Webinars 56:15 An Update on Corticosteroids (October 2018) 6 years ago Care Webinars,Research & Clinical Trial Webinars,Webinars 44:29 Is Myostatin Still a Potential Therapeutic Target? (October 2018) 6 years ago Research & Clinical Trial Webinars,Webinars 1:00:51 Puberty and Duchenne (September 2018) 6 years ago Care Webinars,Webinars 1:09:04 HOPE-2 Duchenne Clinical Trial – Capricor (July 2018) 6 years ago Research & Clinical Trial Webinars,Webinars 1:01:35 Introducing PPMO – Sarepta Therapeutics (May 2018) 6 years ago Research & Clinical Trial Webinars,Webinars 50:18 Roche/Genentech Anti-Myostatin Adnectin RG6206 in Duchenne (May 2018) 6 years ago Research & Clinical Trial Webinars,Webinars «1…1415161718…25»Page 16 of 25
by: Parent Project Muscular Dystrophy
